drugset / Trial / NCT02623803

Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies

NCT02623803 ↗

Phase 4 Completed 48 enrolled Mayo Clinic
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate if a lidocaine infusion will provide benefit to pancreatectomy patients in regards to analgesia and return of bowel function.

Timeline

Start
2016-01
Primary completion
2018-02
Completion
2018-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications